NYSE:MET - Metlife Stock Price, Price Target & More

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Metlife declared a quarterly dividend on Friday, July 6th. Shareholders of record on Monday, August 6th will be paid a dividend of $0.42 per share on Thursday, September 13th. This represents a $1.68 annualized dividend and a yield of 3.74%. The ex-dividend date of this dividend is Friday, August 3rd. View Metlife's Dividend History.

Metlife announced that its Board of Directors has approved a share repurchase plan on Tuesday, May 22nd 2018, which permits the company to buyback $1,500,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to purchase up to 3.1% of its stock through open market purchases. Stock buyback plans are usually a sign that the company's management believes its shares are undervalued.

Metlife Inc (NYSE:MET) issued its quarterly earnings data on Wednesday, May, 2nd. The financial services provider reported $1.36 EPS for the quarter, beating analysts' consensus estimates of $1.17 by $0.19. The financial services provider had revenue of $15.15 billion for the quarter, compared to analysts' expectations of $15.52 billion. Metlife had a return on equity of 8.70% and a net margin of 6.48%. The company's revenue for the quarter was up .6% on a year-over-year basis. During the same period in the previous year, the company posted $1.20 EPS. View Metlife's Earnings History.

17 Wall Street analysts have issued 12-month price objectives for Metlife's shares. Their forecasts range from $47.00 to $78.00. On average, they anticipate Metlife's stock price to reach $56.60 in the next year. This suggests a possible upside of 25.9% from the stock's current price. View Analyst Ratings for Metlife.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 9 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Metlife saw a decline in short interest in the month of June. As of June 29th, there was short interest totalling 12,020,672 shares, a decline of 28.9% from the June 15th total of 16,900,543 shares. Based on an average daily volume of 7,086,353 shares, the days-to-cover ratio is presently 1.7 days. Currently, 1.4% of the company's stock are short sold. View Metlife's Current Options Chain.

Some companies that are related to Metlife include China Life Insurance (LFC), Prudential Public (PUK), AXA (AXAHY), Prudential Financial (PRU), Manulife Financial (MFC), SWISS RE Ltd/S (SSREY), AVIVA PLC/ADR (AVVIY), Sun Life Financial (SLF), HANNOVER RUECK/S (HVRRY), Legal & General Group (LGEN), AMP (AMP), Lincoln National (LNC), OLD Mut PLC/ADR (ODMTY), AEGON (AEG) and Torchmark (TMK).

Headlines about MET stock have trended somewhat positive this week, Accern Sentiment reports. Accern scores the sentiment of press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Metlife earned a coverage optimism score of 0.04 on Accern's scale. They also assigned news articles about the financial services provider an impact score of 45.43 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Metlife's stock is owned by many different of institutional and retail investors. Top institutional investors include BOARD OF DIRECTORS OF METLIFE INC (15.00%), Bank of Montreal Can (0.19%), NN Investment Partners Holdings N.V. (0.17%), Retirement Systems of Alabama (0.06%), Cambiar Investors LLC (0.05%) and Deprince Race & Zollo Inc. (0.05%). Company insiders that own Metlife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for Metlife.

MET stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Calamos Advisors LLC, Welch & Forbes LLC, Gofen & Glossberg LLC IL, Cambiar Investors LLC, Jolley Asset Management LLC, Deprince Race & Zollo Inc. and Gateway Investment Advisers LLC. View Insider Buying and Selling for Metlife.

MET stock was purchased by a variety of institutional investors in the last quarter, including Howard Capital Management Inc., Capital One National Association, Retirement Systems of Alabama, Farmers Trust Co., DAVENPORT & Co LLC, NN Investment Partners Holdings N.V., Addenda Capital Inc. and State of Alaska Department of Revenue. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MET stock can currently be purchased for approximately $44.96.

Metlife has a market capitalization of $45.17 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

Metlife's mailing address is 200 Park Avenue, New York NY, 10166. The financial services provider can be reached via phone at 212-578-9500.